ChiCTR2100042375
结束
/
/
/
2021-01-21
/
/
新型冠状病毒肺炎(COVID-19)
Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan
Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan
74800
To evaluate the association of Serum Procalcitonin and other biochemical markers including ferritin, CRP, IL-6 with severity in Coronavirus disease 2019 (COVID-19), hospitalized patients and to test the hypothesis that they are an independent predictor of mortality.
析因分组（即根据危险因素或暴露因素分组）
探索性研究/预试验
Owing to the retrospective data analysis, biochemical marker levels were obtained within 48 hours of admission for all in patients as routine care protocol of COVID-19.
N/A
No
/
71;86
/
2020-03-01
2020-08-10
/
both genders and aged 18 years and older groups with SARS-CoV-2 positive on a reverse-transcriptase polymerase chain reaction (PCR) test and received treatment at our center；
登录查看1) biochemical work up on admission not undertaken; 2) known thalassemic cases.；
登录查看No
74800
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
